PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients

Li Bin; Lin Zhe; Liang Quan; Hu Yuan; Xu Wen-Feng

doi:10.1515/biol-2018-0061

Open Life Sciences (Dec 2018)

PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients

Li Bin,
Lin Zhe,
Liang Quan,
Hu Yuan,
Xu Wen-Feng

Affiliations

Li Bin: Department of Urology Surgery, The First People’s Hospital of Foshan, No.81 LingNan Road, Foshan, GuangDong 528000, P.R. China
Lin Zhe: Department of Urology Surgery, The First People’s Hospital of Foshan, No.81 LingNan Road, Foshan, GuangDong 528000, P.R. China
Liang Quan: Department of Urology Surgery, The First People’s Hospital of Foshan, No.81 LingNan Road, Foshan, GuangDong 528000, P.R. China
Hu Yuan: Department of Urology Surgery, The First People’s Hospital of Foshan, No.81 LingNan Road, Foshan, GuangDong 528000, P.R. China
Xu Wen-Feng: Department of Urology Surgery, The First People’s Hospital of Foshan, No.81 LingNan Road, Foshan, GuangDong 528000, P.R. China

DOI: https://doi.org/10.1515/biol-2018-0061
Journal volume & issue: Vol. 13, no. 1
pp. 511 – 517

Abstract

Read online

This study aimed to evaluate the expression of progestin and adipoQ receptor family member VI (PAQR6, mPRδ) in prostate cancer and to explore its role in prostate cancer progression.

Published in Open Life Sciences

ISSN: 2391-5412 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Science: Biology (General)
Website: http://www.degruyter.com/view/j/biol

About the journal

Abstract

Keywords